View Discovery

Clinical Pipeline

Learn more about our pipeline

Trials for Market Approval Download PPT

Pre-Clinical (GLP)

Foundation for Neglected Disease Research
GlaxoSmithKline, Bill & Melinda Gates Foundation
Institute of Materia Medica, CAMS & PUMC
National Centre of Oceanic and Antarctic Research (NCAOR), Gao, India
Guangzhou Institute of Respiratory Medicine Company Limited, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
Microbiotix, Inc.

Phase 1

TB Alliance, University of Auckland, Merck & Co., Inc.
GlaxoSmithKline, TB Drug Accelerator, Bill & Melinda Gates Foundation
TB Alliance, Institute of Materia Medica
iM4TB - Innovative Medicines for Tuberculosis, Bill & Melinda Gates Foundation
TB Alliance, Bill & Melinda Gates Medical Research Institute, Foundation for Neglected Disease Research

Phase 2

University of Munich, Hans-Knöll Institute, Jena, German Center for Infection Research (DZIF), European and Developing Countries Clinical Trials Partnership (EDCTP), Radboud University
Qurient Co., Ltd, Qurient Co. Ltd. / LLC "Infectex", a portfolio firm of Maxwell Biotech Venture Fund
Nearmedic Plus LLC
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sequella, Inc, TB Alliance
Sequella, Inc